Race may play a role in the waitlist experience, allograft quality and transplant outcomes of patients with autosomal ...

But if not, you'll need to find stocks that hold the potential to pack more punch. The past doesn't predict the future, but ...

Out of six evaluable patients on that dose ... and early-stage candidate VX-407 for autosomal dominant polycystic kidney disease. Bank of America analysts said in a research note that the deal ...

Today’s burning question from Cochlear's (ASX:COH) poorly received interim results is whether users are on a buyer’s strike ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

The following is a summary of “Treating chronic kidney disease in Danish primary care: results from the observational ATLAS study,” published in the February 2025 issue of BMC Primary Care by ...

In December 2023, through the development efforts of CRISPR Therapeutics and Vertex Pharmaceuticals, their decades-long ...

Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...

From life-altering genetic conditions to promising new treatments, here's what you need to know about 7 inherited diseases ...

Researchers have demonstrated the feasibility of a morphological-based approach to interpreting spatial transcriptomic (ST) data, helping to improve understanding of the lesions that occur in chronic ...

Elevated fat levels in your liver can raise your chances of developing serious health issues, including diabetes, ...